3 main facts you need to know about Antibody Drug Conjugates (ADCs)

ADCs are innovative therabees

1. A new class of biopharmaceutical drugs used to treat cancer

2. A more precise anti-tumor targeting 

3. A stronger therapeutic effectiveness

4. A better quality of life for patients

With a potent future

4 ADCs launched

85 ADCs in active clinical development

They are composed of 3 elements

mAb (Monoclonal AntiBody): Specific protein that recognizes and targets cancer cells

Payload: Highly active ingredient that kills cancer cells

Linker: Small molecule that connects the cytotoxic payload to the mAb

Do you want to learn more? 

Watch the video